- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07642284
Clinical Performance of AH Plus Jet® Root Canal Sealers in Single-cone Protocols
A Prospective, Parallel-group, Randomized Clinical Investigation Evaluating Performance and Safety of the AH Plus Jet® Sealing Materials Used in Single-cone Technique for Single Visit Endodontic Treatment. A 2-year Follow-up Study
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Mikaela Friberg
- Telefonnummer: +46 702 644 357
- E-mail: mikaela.friberg@dentsplysirona.com
Undersøgelse Kontakt Backup
- Navn: Ulrika Bonander
- Telefonnummer: +46 706 440 844
- E-mail: ulrika.bonander@dentsplysirona.com
Studiesteder
-
-
New York
-
New York, New York, Forenede Stater, 10010
- New York University College of Dentistry
-
Kontakt:
- Matthew Malek
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Adult aged 18-75 at time of informed consent.
- Subject willing to participate in the clinical investigation and able to understand the content of the clinical investigation.
- Subject willing to return for follow-up visits.
- Subject has signed and dated the informed consent form.
- Subject in need of one or two primary root canal treatment on mature permanent anterior (incisor or canine) or premolar tooth.
- Planned study tooth has a favorable prognosis for the next 2 years.
Exclusion Criteria:
- History of allergic reaction to epoxy resins or amines or any of the other product components.
- Subject has significant systemic health issues or chronic conditions (American Society of Anesthesiologists (ASA) class 3-6).
- Known pregnancy or is breastfeeding at time of enrolment or at the RCT visit.
- Subject unlikely to comply with investigational procedures, as judged by the Investigator.
- Sign of sinus tract or gingival swelling in the planned study position.
- Previous enrolment in the present clinical investigation.
- Involvement in the planning and conduct of the clinical investigation (applies to both Dentsply Sirona personnel and the clinical investigation site).
- Participation in another clinical investigation that may interfere with the present clinical investigation.
- Subject experiencing an intraoperative condition that may interfere with the evaluation of the investigational root canal sealer.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Investigation medical Device 1 (IMD1)
Endodontic sealer material with a modified formula compared to the predicate.
|
AH Plus® endodontic sealer is a class IIa medical device used for permanent obturation of root canals of teeth of the secondary dentition in combination with root canal points, for subjects in need of endodontic treatment to restore a tooth. AH Plus Jet® Endodontic Sealer has similar intended use and the same indications for use as the predicate Root Canal Sealer (AH Plus Jet® Root Canal Sealing Material). However, there are minor differences in the technological characteristics. |
|
Aktiv komparator: Investigation medical Device 2 (IMD2)
Predicate endodontic sealer material.
|
AH Plus® endodontic sealer is a class IIa medical device used for permanent obturation of root canals of teeth of the secondary dentition in combination with root canal points, for subjects in need of endodontic treatment to restore a tooth. AH Plus Jet® Root Canal Sealing Material is a predicate to AH Plus Jet® Endodontic Sealer. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Endodontic treatment success
Tidsramme: At 1 year after Root Canal Treatment (RCT) visit (RCT visit conducted a maximum 2 months after day 0).
|
Endodontic treatment success according to loose criteria after 1 year, defined as "Tooth with successful endodontic treatment according to loose criteria (Yes/No)". The endodontic treatment is considered a failure according to the loose criteria under any of the following criteria:
|
At 1 year after Root Canal Treatment (RCT) visit (RCT visit conducted a maximum 2 months after day 0).
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Endodontic treatment success
Tidsramme: At 6 months and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
Endodontic treatment success according to loose criteria after 6 months and 2 years, defined as "Tooth with successful endodontic treatment according to loose criteria (Yes/No)". The endodontic treatment is considered a failure according to the loose criteria under any of the following criteria:
|
At 6 months and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
|
Endodontic treatment success
Tidsramme: At 6 months, 1 year and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
Endodontic treatment success according to strict criteria after 6 months, 1 and 2 years. The endodontic treatment is considered a failure according to the strict criteria under any of the following criteria:
|
At 6 months, 1 year and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
|
Intensity of patient-reported short-term post-operative pain
Tidsramme: At 7 days +/- 3 days after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
Short-term self-reported post-operative pain level of study tooth using Numeric Rating Scale (NRS) 0-10, where 0 is no pain and 10 is worst possible pain.
|
At 7 days +/- 3 days after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
|
Correlation between coping strategy scores and patient-reported short-term post-operative pain intensity levels - Active coping.
Tidsramme: At RCT visit and at 6 months, 1 year and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
Patient completed questionnaire consisting of 27 questions. The patient will have an option to select a number between 0-6 in response to each question where a 0 indicates you never do that when you experience pain, a 3 indicates you sometimes do that when you experience pain, and a 6 indicates you always do it when you are experiencing pain. The scores will be categorized into mean values resulting in "active coping" or "passive coping" as listed below and will be correlated to patient-reported short-term post-operative pain intensity levels. Active Coping is the mean of the following categories; Diverting Attention (questions 2, 15, 16, 25 and 26), Reinterpreting Pain Sensations (questions 1, 9, 18 and 27), Coping Statements (questions 4, 5, 11 and 20), and Ignoring Pain Sensations (questions 10, 12, 13, 19 and 22). |
At RCT visit and at 6 months, 1 year and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
|
Correlation between coping strategy scores and patient-reported short-term post-operative pain intensity levels - Passive coping.
Tidsramme: At RCT visit and at 6 months, 1 year and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
Patient completed questionnaire consisting of 27 questions. The patient will have an option to select a number between 0-6 in response to each question where a 0 indicates you never do that when you experience pain, a 3 indicates you sometimes do that when you experience pain, and a 6 indicates you always do it when you are experiencing pain. The scores will be categorized into mean values resulting in "active coping" or "passive coping" as listed below and will be correlated to patient-reported short-term post-operative pain intensity levels. Passive Coping is the mean of the following categories; Praying & Hoping (questions 8, 17 and 23) and Catastrophizing (questions 3, 6, 7, 14, 21 and 24). |
At RCT visit and at 6 months, 1 year and 2 years after RCT visit (RCT visit conducted a maximum 2 months after day 0).
|
|
Occurrence of Adverse Events, Adverse Device Effects, and Device Deficiencies during the clinical investigation.
Tidsramme: From Day 0 up to completion of the 2-year follow-up visit, on average 2 years and 2 months.
|
Adverse Events, Adverse Device Effects, and Device Deficiencies spontaneously reported, and collection at each clinical investigation visit.
|
From Day 0 up to completion of the 2-year follow-up visit, on average 2 years and 2 months.
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- C-EN-24-019
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Rodbehandling
-
Tanta UniversityIkke rekrutterer endnuRoot Canal Endelig kunstvandingsaktiveringsteknikkerEgypten
-
University of OxfordMedical Research Council; P1vital Products LimitedAfsluttetEmotion | Bright Light Treatment | AnsigtsudtryksgenkendelseDet Forenede Kongerige
-
Soroka University Medical CenterAfsluttetOptimering af Second Line Treatment Protocol for H Pylori-udryddelseIsrael
-
Elazıg Fethi Sekin Sehir HastanesiAfsluttetNethindens nervefiberlagtykkelse | Pneumatisering af Processus Clinoid Anterior | Optic Canal MorfometriTyrkiet (Türkiye)
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeAnal planocellulært karcinom | Anal basaloid karcinom | Anal Canal Cloacogenic Carcinom | Metastatisk analkanalcarcinom | Tilbagevendende analkanalcarcinom | Stadie IIIB Anal Canal Cancer | Stadie IV Anal Canal CancerForenede Stater
-
Peking University Sixth HospitalIkke rekrutterer endnuKognitiv svækkelse | Major Depressive Disorder (MDD) | Neuroimaging | Bright Light TreatmentKina
-
New York State Psychiatric InstituteAfsluttetAfdækning af neurale og immune mekanismer for kroniske smerter i efterbehandling Lyme syndrom (PTLS)Kronisk smerte | Post Treatment Lyme Syndrome (PTLS)Forenede Stater
-
AHS Cancer Control AlbertaUkendt
-
Medical University of GrazAfsluttet
-
AHS Cancer Control AlbertaRekrutteringAnal Canal CancerCanada
Kliniske forsøg med AH Plus Jet® Endodontic Sealer
-
National University Hospital, SingaporeAktiv, ikke rekrutterende
-
Juan Gonzalo OlivieriRekrutteringEndodontisk sygdom | Endodontisk behandlede tænderSpanien
-
pfm medical gmbhAfsluttetPatienttilfredshed | Vaskulær adgangshavnTyskland